Outset Medical (OM) AGM 2026 summary
Event summary combining transcript, slides, and related documents.
AGM 2026 summary
4 Jun, 2026Opening remarks and agenda
Chair and CEO welcomed stockholders, introduced board members, CFO, and independent auditor present at the meeting.
Inspector of Election and proxy service provider were introduced, and the agenda was posted on the virtual meeting website.
Shareholder proposals
Three formal items were considered: election of two Class III directors, advisory vote on 2025 executive compensation, and ratification of the independent auditor for 2026.
Overview of voting outcomes
Both director nominees were elected to serve until the 2029 annual meeting.
Advisory approval of 2025 executive compensation passed.
Ratification of KPMG LLP as independent auditor for 2026 was approved.
Official voting results will be filed on Form 8-K with the SEC within four business days.
Latest events from Outset Medical
- Q3 momentum and customer expansion underpin growth plans, with next-gen rollout extending into 2027.OM
Stifel 2026 Healthcare Conference 2026 - Tablo combines scaled hospital adoption with recurring revenue and a home-care growth opportunity.OM
Investor presentation - Revenue rose 14% as gross margin improved; FY26 revenue guidance was reiterated.OM
Q3 2026 - FY23 growth and margin gains underpin FY24 revenue and margin targets.OM
Q4 2023 - Q2 2026 revenue grew 1% to $31.6M, gross margin reached 42.2%, and a $40M HCA deal boosts outlook.OM
Q2 2026 - Next-gen Tablo launch and console refresh cycle set to drive growth and profitability in 2026.OM
RBC Capital Markets Global Healthcare Conference 2026 - Q1 revenue fell 6% but gross margin hit 43.4% and net loss narrowed to $19.0 million.OM
Q1 2026 - 2025 revenue up 5%, gross margin expands, net loss narrows, and FDA clearance drives 2026 growth.OM
Q4 2025 - Q1 2025 revenue up 6% to $29.8M, gross margin and liquidity improved, net loss narrowed.OM
Q1 2025